PRIMARY STUDY
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
Key Findings: ß-Caryophyllene (BCP) has potential anti-inflammatory and anti-viral effects against COVID-19 corona virus.
Type of Study: Meta-analysis
Study Result: Inconclusive
Study Location(s): India, United Arab Emirates
Year of Pub: 2021
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Terpenes Studied: ß-Caryophyllene
Receptors Studied: CB2, PPAR - Alpha, GPCR, TRPs, PPARs
